Co-Authors
This is a "connection" page, showing publications co-authored by Michelle Willicombe and Sarah Gleeson.
Connection Strength
1.275
-
Answering the call to action: rapid implementation of an in-center hemodialysis SARS-CoV-2 vaccination program. Kidney Int. 2021 05; 99(5):1238-1239.
Score: 0.234
-
Resuming Deceased Donor Kidney Transplantation in the COVID-19 Era: What Do Patients Want? Transplant Direct. 2021 Apr; 7(4):e678.
Score: 0.233
-
Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. Lancet. 2021 03 27; 397(10280):1178-1181.
Score: 0.233
-
Identification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening. Transplantation. 2021 01 01; 105(1):151-157.
Score: 0.230
-
Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients. J Am Soc Nephrol. 2020 12; 31(12):2753-2756.
Score: 0.228
-
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression. Ann Rheum Dis. 2021 10; 80(10):1322-1329.
Score: 0.060
-
Informing the Risk of Kidney Transplantation Versus Remaining on the Waitlist in the Coronavirus Disease 2019 Era. Kidney Int Rep. 2021 Jan; 6(1):46-55.
Score: 0.057